Ticker Symbol: SLNO
Soleno Therapeutics Inc
$0.76 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001484565
Company Profile
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3845
Address: 1235 Radio Rd Ste 110
Website: soleno.life
CEO: Anish Bhatnagar
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $25.56
Change:
-$0.92
(
-3.47%)
Days Range: $24.51 - $26.99
Beta: -2.60
52wk. High: $30.30
52wk. Low: $0.85
Ytd. Change 1233.90%
50 Day Moving Average: $15.77
200 Day Moving Average: $7.33
Shares Outstanding: 9992178
Valuation
Market Cap: 25.5B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A